LexisNexis folding Health Market Science into its brand family
ATLANTA — LexisNexis Risk Solutions, a provider of data, analytics and technology, on Thursday announced the brand transition of Health Market Science into the LexisNexis brand family.
The rebranding will begin in the fourth quarter of 2015 for the life sciences market, as well as other health care segments LexisNexis currently serves, to streamline branding efforts and reflect the organization’s commitment to combining its public records footprint, provider and claims data, analytics and big data technology.
“It’s a good time for our brand to reflect what LexisNexis brings to life sciences companies in terms of superior provider data knowledge, market intelligence and agile data management that helps our customers answer critical business questions resulting in operational effectiveness and efficiency,” said Theresa Greco, VP, Life Sciences, LexisNexis Risk Solutions.
LexisNexis health care solutions portfolio includes a provider referential database, which blends thousands of data sources, verification techniques and analytics. The company leverages proprietary linking algorithms and technology to match and build relationships across data sources and also delivers customized intelligence to meet the customer’s need.
Missing or outdated information about health care provider specialties and critical affiliations and organizational structures puts life sciences companies’ competitive advantages at risk. Armed with better health care practitioner information, they can move to account-based selling—targeting and reaching the right providers, at the right time, with the right information and in the right way. Life Sciences companies can also achieve compliance and commercial agility by leveraging the LexisNexis real-time data management and analytics solution, LexisNexis Agile Data Management.
“The acquisition of Health Market Science establishes LexisNexis as the health care authority on provider data and data management,” said Lee Rivas, CEO, Public Sector and Health Care, LexisNexis Risk Solutions. “Together, we deliver more accurate and comprehensive data-driven analytic solutions and services. This customer-centric approach, coupled with the experience of specialized health care data experts, enables transformation within the Life Sciences industry.”
Touro College of Pharmacy students organize ‘Operation Immunization’
Left to right: Touro College of Pharmacy students Rachel Jakobov; Tinnie Liao-Ng Yan; Christine Nguyen, and Angela Pantanawong
NEW YORK — Touro College of Pharmacy students provided vaccines to seniors this week as part of its third annual “Operation Immunization” as one of four events held in support of Flu Awareness Month and American Pharmacists Month, which included a flu clinic at TCOP, a lecture from a developer of the flu vaccine and a documentary on the 1918 Spanish Flu pandemic.
At “Operation Immunization” — which was organized by the college’s chapter of the American Pharmacists Association-Academy of Student Pharmacists — students screened seniors in East Harlem to ensure they could receive vaccines that were then administered by registered pharmacists.
“We are very committed to contributing our expertise in preventative medicine within the Harlem community and are proud of the contributions our students make to this significant public health initiative,” TCOP interim dean Dr. Zvi Loewy said.
Working with Rite Aid as a community partner, students organized the entirety of “Operation Immunization”, building on the pharmacists’ role in working to improve public health and gaining experience in patient interaction and meeting seniors’ needs.
"It's vitally important for seniors to receive vaccinations because adults over 65 years of age are more susceptible to the flu and also prone to other preventable diseases as well,” event organizer Christine Nguyen said. “As student pharmacists, it was our goal to administer as many immunizations as possible in order to do our part in protecting our senior population.”
Diplomat Pharmacy announces 2 C-suite promotions
FLINT, Mich. — Diplomat Pharmacy earlier this week announced two promotions within the company's executive leadership team as part of a strategic move to align efforts for internal improvement.
Robert Fleckenstein, previously VP operations, has been promoted to SVP operations. Fleckenstein's advancement adds focus to the company's total enterprise operations, including remote locations and subsidiary companies.
Gary Rice, previously VP clinical services, has been promoted to SVP cinical services, education and human resources. Rice's appointment brings clinical efforts, employee education, employee engagement and quality improvement into the same segment of the company.
Fleckenstein oversees day-to-day operations of Diplomat's national distribution center, patient service operations, call center, remote sites and other patient-facing services at Diplomat. Before joining Diplomat in June 2010, Fleckenstein was VP pharmacy operations at Allion Healthcare and at CVS ProCare Mail Service. Previously, he served as regional manager of oncology pharmaceutical services at US Oncology, director of pharmacy and customer service at Stadtlander Drug Company and general manager at Healthcare Management/Murray Pharmacy.
"We have made substantial investments in our technology, infrastructure and service lines to build a scalable foundation for constant improvement in patient care and growth," said Gary Kadlec, president of Diplomat. "Through Robert's steady management we continue our enhancement of key operating metrics. I can personally attest to his deep industry acumen and his commitment to all that we do."
Prior to joining Diplomat in June 2011, Rice was VP operations at ITSRx, where he provided operational and clinical leadership for the development of specialty and retail pharmacies. Rice also served as director of specialty clinical management for MedImpact Healthcare Systems. He directed oncology strategy, specialty pharmacy sales management, clinical guidance of specialty medication providers and the clinical protocol development of 15 specialty therapy categories. Before MedImpact, he was VP retail and ancillary services and director of pharmaceutical services at the Kelsey-Seybold Clinic in Houston.
"Our focus as a company continues to be on our clinical excellence and care to our patients. This is truly our Diplomat Difference," Kadlec said. "We are committed to continually enhancing our abilities in all of these areas and look for Gary Rice and his team to carry us to that next step. We have a very rare resource in our Diplomat University, where our intent with every new hire is to improve the quality and clinical results for our patients. With this clear path before us the alignment of Diplomat University, Clinical Services and Human Resources, all within the sponsorship of Gary Rice, will best optimize how these groups work together."
Loading Post Please Wait...